Abstract
BACKGROUND: Methadone is effective treatment for opioid addiction, but regulations restrict its use. Methadone medical maintenance treats stabilized methadone patients in a medical setting, but only experimental programs have been studied.
OBJECTIVE: To evaluate the implementation of the first methadone medical maintenance program established outside a reseach setting.
DESIGN: One-year program evaluation.
SETTING: A public hospital and a community opioid treatment program.
PARTICIPANTS: Methadone patients with > 1 year of clinical stability. Eleven generalist physicians and 4 hospital pharmacists.
INTERVENTIONS: Regulatory exemptions were requested. Physicians and pharmacists were trained. Patients were transferred to the medical setting and permitted 1-month supplies of methadone.
MEASUREMENTS: Patient eligibility and willingness to enroll, treatment retention, urine toxicology results, change in addiction severity and functional status, medical services provided, patient and physician satisfaction, and physician attitudes toward methadone maintenance.
RESULTS: Regulatory exemptions were obtained after a 14-month process, and the program was cited in federal policy as acceptable for widespread implementation. Forty-nine of 684 patients (7.2%) met stability criteria, and 30 enrolled. Twenty-eight were retained for 1 year, and 2 transferred to other programs. Two patients had opioid-positive urine tests and were managed in the medical setting. Previously unmet medical needs were addressed, and the Addiction Severity Index (ASI) medical composite score improved over time (P=.02). Patient and physicia satisfaction were high, and physician attitudes toward methadone maintenance treatment became more positive (P=.007).
CONCLUSIONS: Methadone medical maintenance is complex to arrange but feasible outside a research setting, and can result in good clinical outcomes.
Similar content being viewed by others
References
Dole VP. Implications of methadone maintenance for theories of narcotic addiction. JAMA. 1988;260:3025–9.
Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA. 1998;280:1936–43.
Barnett PG, Hui SS. The cost-effectiveness of methadone maintenance. Mt Sinai J Med. 2000;67:365–74.
Ball J. The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcomes. New York, NY: Springer-Verlag; 1991.
Sees KL, Delucchi KL, Masson C, et al. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA. 2000;283:1303–10.
Gossop M, Marsden J, Stewart D, Treacy S. Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend. 2001;62:255–64.
Rettig RA, Yarmolinsky A, eds. Federal Regulation of Methadone Treatment. Washington, DC: National Academy Press; 1995.
Merrill JO. Policy progress for physician treatment of opiate addiction. J Gen Intern Med. 2002;17:361–8.
Novick DM, Pascarelli EF, Joseph H, et al. Methadone maintenance patients in general medical practice. A preliminary report. JAMA. 1988;259:3299–302.
Novick DM, Joseph H. Medical maintenance: the treatment of chronic opiate dependence in general medical practice. J Subst Abuse Treat. 1991;8:233–9.
Novick DM, Richman BL, Friedman JM, et al. The medical status of methadone maintenance patients in treatment for 11–18 years. Drug Alcohol Depend. 1993;33:235–45.
Salsitz EA, Joseph H, Frank B, et al. Methadone medical maintenance (MMM): treating chronic opioid dependence in private medical practice—a summary report (1983–1998). Mt Sinai J Med. 2000;67:388–97.
Schwartz RP, Brooner RK, Montoya ID, Currens M, Hayes M. A 12-year follow-up of a methadone medical maintenance program. Am J Addict. 1999;8:293–9.
King VL, Stoller KB, Hayes M, et al. A multicenter randomized evaluation of methadone medical maintenance. Drug Alcohol Depend. 2002;65:137–48.
Senay EC, Barthwell A, Marks R, Bokos PJ. Medical maintenance: an interim report. J Addict Dis. 1994;13:65–9.
McLellan AT, Kushner H, Metzger D, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9:199–213.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.
Fiellin DA, O’Connor PG, Chawarski M, Pakes JP, Pantalon MV, Schottenfeld RS. Methadone maintenance in primary care: a randomized controlled trial. JAMA. 2001;286:1724–31.
Caplehorn JR, Irwig L, Saunders JB. Attitudes and beliefs of staff working in methadone maintenance clinics. Subst Use Misuse. 1996;31:437–52.
Caplehorn JR, Hartel DM, Irwig L. Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics. Subst Use Misuse. 1997;32:399–413.
McNeely J, Drucker E, Hartel D, Tuchman E. Office-based methadone prescribing: acceptance by inner-city practitioners in New York. J Urban Health. 2000;77:96–102.
Lepay D, Clark HW. Federal Advisory on Methadone Medical Maintenance Exemptions. Washington, DC: Department of Health and Human Services; 2000
Senay EC, Barthwell AG, Marks R, Bokos P, Gillman D, White R. Medical maintenance: a pilot study. J Addict Dis. 1993;12:59–76.
Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y. Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA. 2001;286:1715–23.
Laine C, Hauck WW, Gourevitch MN, Rothman J, Cohen A, Turner BJ. Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs. JAMA. 2001;285:2355–62.
Willenbring ML, Olson DH. A randomized trial of integrated outpatient treatment for medically ill alcoholic men. Arch Intern Med. 1999;159:1946–52.
Friedmann PD, Zhang Z, Hendrickson J, Stein MD, Gerstein DR. Effect of primary medical care on addiction and medical severity in substance abuse treatment programs. J Gen Intern Med. 2003;18:1–8.
Caplehorn JR, Lumley TS, Irwig L. Staff attitudes and retention of patients in methadone maintenance programs. Drug Alcohol Depend. 1998;52:57–61.
Weinrich M, Stuart M. Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy. JAMA. 2000;283:1343–8.
Hutchinson SJ, Taylor A, Gruer L, et al. One-year follow-up of opiate injectors treated with oral methadone in a GP-centred programme. Addiction. 2000;95:1055–68.
Gossop M, Stewart D, Browne N, Marsden J. Methadone treatment for opiate dependent patients in general practice and specialist clinic settings: outcomes at 2-year follow-up. J Subst Abuse Treat. 2003;24:313–21.
Brands J, Brands B, Marsh D. The expansion of methadone prescribing in Ontario, 1996–1998. Addict Res. 2000;8:485–96.
Fiellin DA, O’Connor PG. Clinical practice. Office-based treatment of opioid-dependent patients. N Engl J Med. 2002;347:817–23.
Opioid drugs in maintenance and detoxification treatment of opiate addiction; Substance Abuse and Mental Health Services Administration, Department of Health and Human Services. Final rule. Fed Regist. 2001;66:4076–102.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was assisted by a grant from the Robert Wood Johnson Foundation Substance Abuse Policy Research Program (RWJF grant 34895).
Rights and permissions
About this article
Cite this article
Merrill, J.O., Jackson, T.R., Schulman, B.A. et al. Methadone medical maintenance in primary care. J GEN INTERN MED 20, 344–349 (2005). https://doi.org/10.1111/j.1525-1497.2005.04028.x
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1525-1497.2005.04028.x